Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy

Epilepsia

Volumn 42, Issue 8, 2001, Pages 1002-1006

  Stephen, Linda J ^a   Kwan, Patrick ^a   Shapiro, David ^b   Dominiczak, Marek ^b   Brodie, Martin J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Insulin; Lamotrigine; Lipids; Sodium valproate; Testosterone

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CHOLESTEROL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LAMOTRIGINE; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; PRASTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG EFFECT; ENDOCRINE DISEASE; EPILEPSY; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENSTRUAL IRREGULARITY; MONOTHERAPY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RISK FACTOR; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTICONVULSANTS; BLOOD GLUCOSE; BODY MASS INDEX; COMORBIDITY; DEHYDROEPIANDROSTERONE; EPILEPSY; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; LIPIDS; MALE; MENSTRUATION DISTURBANCES; OBESITY; POLYCYSTIC OVARY SYNDROME; SEX FACTORS; TESTOSTERONE; TRIAZINES; TRIGLYCERIDES; VALPROIC ACID;

EID: 0034864141     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.0420081002.x     Document Type: Article

References (41)

1. Antiepileptic drugs
2. β-oxidation of valproic acid, I: Effects of fasting and glucose in humans
3. Valproic acid: A reappraisal of its pharmacological properties and clinical efficacy in epilepsy
4. Weight gain during treatment with valproate
5. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalised tonic-clonic seizures in adults
6. Valproate-associated weight gain: Potential relation to energy expenditure and metabolism in patients with epilepsy
7. The effects of valproate, carbamazepine and oxcarbazepine on growth and sexual maturation in girls with epilepsy
8. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy
9. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy
10. Obesity and endocrine disorders in women taking valproate for epilepsy
11. Polycystic ovarian syndrome in women with epilepsy: Epileptic or iatrogenic?
12. Valproate, lamotrigine and insulin-mediated risks in women with epilepsy
13. Polycystic ovarian syndrome: The metabolic syndrome comes to gynaecology
14. Polycystic ovary syndrome
15. The role of hyperinsulinaemia in the pathogenesis of ovarian hyperandrogenism
16. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases
17. Varying body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1988 to 1994)
18. Pathogenesis of polycystic ovary syndrome: The enigma unravels?
19. Polycystic ovaries: A common finding in normal women
20. The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: Predictive power of endocrine tests
21. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives
22. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterisation
23. Issues in testosterone replacement in older men
24. Polycystic ovarian syndrome: The spectrum of the disorder in 1741 patients
25. Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries
26. 5-androstanediols
27. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotrophin-releasing hormone agonist
28. The role of adrenal hyperandrogenism, insulin resistance and obesity in the pathogenesis of polycystic ovarian syndrome
29. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome
30. Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovarian syndrome
31. Clinical implications of hyperinsulinaemia in women
32. Insulin resistance and the polycystic ovarian syndrome: Mechanisms and implication for pathogenesis
33. Obesity, insulin resistance and its links to non-insulin-dependent diabetes mellitus
34. Polycystic ovary syndrome in patients with focal epilepsy: A study in 93 women
35. Circulating hormones and pituitary responsiveness in young men receiving long-term antiepileptic medication
36. Serum hormones in male patients receiving anticonvulsant medication
37. Reproductive function in epilepsy
38. A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy
39. Reduced fertility and neuroendocrine dysfunction in women with epilepsy
40. Ovulatory function in epilepsy
41. Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication